Seabrook TJ - Search Results

1

Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.

Seabrook TJ, Iglesias M, Bloom JK, Spooner ET, Lemere CA. Seabrook TJ, et al. Vaccine. 2004 Sep 28;22(29-30):4075-83. doi: 10.1016/j.vaccine.2004.03.061. Vaccine. 2004. PMID: 15364459

2

Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice.

Lemere CA, Spooner ET, Leverone JF, Mori C, Iglesias M, Bloom JK, Seabrook TJ. Lemere CA, et al. Among authors: seabrook tj. Neurochem Res. 2003 Jul;28(7):1017-27. doi: 10.1023/a:1023203122036. Neurochem Res. 2003. PMID: 12737526 Review.

3

Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.

Lemere CA, Beierschmitt A, Iglesias M, Spooner ET, Bloom JK, Leverone JF, Zheng JB, Seabrook TJ, Louard D, Li D, Selkoe DJ, Palmour RM, Ervin FR. Lemere CA, et al. Among authors: seabrook tj. Am J Pathol. 2004 Jul;165(1):283-97. doi: 10.1016/s0002-9440(10)63296-8. Am J Pathol. 2004. PMID: 15215183 Free PMC article.

4

Species-specific immune response to immunization with human versus rodent A beta peptide.

Seabrook TJ, Bloom JK, Iglesias M, Spooner ET, Walsh DM, Lemere CA. Seabrook TJ, et al. Neurobiol Aging. 2004 Oct;25(9):1141-51. doi: 10.1016/j.neurobiolaging.2003.12.008. Neurobiol Aging. 2004. PMID: 15312960

5

Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G).

Maier M, Seabrook TJ, Lemere CA. Maier M, et al. Among authors: seabrook tj. Vaccine. 2005 Oct 25;23(44):5149-59. doi: 10.1016/j.vaccine.2005.06.018. Vaccine. 2005. PMID: 16054274

6

Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.

Maier M, Seabrook TJ, Lazo ND, Jiang L, Das P, Janus C, Lemere CA. Maier M, et al. Among authors: seabrook tj. J Neurosci. 2006 May 3;26(18):4717-28. doi: 10.1523/JNEUROSCI.0381-06.2006. J Neurosci. 2006. PMID: 16672644 Free PMC article.

7

Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.

Seabrook TJ, Thomas K, Jiang L, Bloom J, Spooner E, Maier M, Bitan G, Lemere CA. Seabrook TJ, et al. Neurobiol Aging. 2007 Jun;28(6):813-23. doi: 10.1016/j.neurobiolaging.2006.04.007. Epub 2006 May 24. Neurobiol Aging. 2007. PMID: 16725229

8

Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.

Maier M, Seabrook TJ, Lemere CA. Maier M, et al. Among authors: seabrook tj. Neurodegener Dis. 2005;2(5):267-72. doi: 10.1159/000090367. Neurodegener Dis. 2005. PMID: 16909008 Review.

9

Novel Abeta immunogens: is shorter better?

Lemere CA, Maier M, Peng Y, Jiang L, Seabrook TJ. Lemere CA, et al. Among authors: seabrook tj. Curr Alzheimer Res. 2007 Sep;4(4):427-36. doi: 10.2174/156720507781788800. Curr Alzheimer Res. 2007. PMID: 17908047 Review.

10

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans.

Lemere CA, Maier M, Jiang L, Peng Y, Seabrook TJ. Lemere CA, et al. Among authors: seabrook tj. Rejuvenation Res. 2006 Spring;9(1):77-84. doi: 10.1089/rej.2006.9.77. Rejuvenation Res. 2006. PMID: 16608400 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters